Edit
Axial Therapeutics
https://www.axialbiotherapeutics.com/Last activity: 02.04.2020
Probably Closed - Reference to Axial Therapeutics, Inc.
Axial Therapeutics is a biotechnology company fundamentally changing the treatment of neurological diseases and disorders by harnessing groundbreaking science in the microbiome-gut-brain axis.
Total raised: $54.15M
Investors 1
| Date | Name | Website |
| - | Taiho Vent... | taihoventu... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 20.06.2019 | Series B | $10M | Taiho Vent... |
| 27.02.2019 | Series B | $25M | - |
| 01.12.2016 | Series A | $19.15M | - |
Mentions in press and media 21
| Date | Title | Description |
| 02.04.2020 | Sue Desmond-Hellmann joins Pfizer board; Kite Pharma taps ally in push to expand CAR-T | → Sue Desmond-Hellmann will be joining Pfizer’s board of directors, four months after stepping down as CEO of the Bill and Melinda Gates Foundation. The American pharma giant has attracted a star-studded board, most recent... |
| 27.06.2019 | Gut-Targeted Therapeutics Company Axial Biotherapeutics Raises $10 Million | Axial Biotherapeutics, a biotech company dedicated to building gut-targeted therapeutics, announced it raised $10 million Axial Biotherapeutics, a biotechnology company dedicated to building a unique class of gut-targeted therapeutics for n... |
| 21.06.2019 | How Slack Made Other Startup CEOs Wealthy: Term Sheet | SLACK SOARS Slack killed it. Paid Content You can't secure what you can't see From ExtraHop Yesterday, I noted that Accel had a big windfall thanks to Slack’s public market debut. But I read an interesting story in Forbes that talks about h... |
| 20.06.2019 | Axial Biotherapeutics Announces $10M Investment from Taiho Ventures | WALTHAM, Mass.--(BUSINESS WIRE)--Axial Biotherapeutics, a biotechnology company dedicated to building a unique class of gut-targeted therapeutics for neurodegenerative diseases and neurodevelopmental disorders, today announced a direct inve... |
| 20.06.2019 | Axial Biotherapeutics Raises $10M in Series B Extension Funding | Axial Biotherapeutics, a Waltham, MA-based biotechnology company dedicated to building gut-targeted therapeutics for neurodegenerative diseases and neurodevelopmental disorders, raised $10m in Series B extension funding. Taiho Ventures made... |
| 20.06.2019 | Axial Biotherapeutics Receives $10M | WALTHAM, MA, Axial Biotherapeutics today announced a direct investment of $10 million from Taiho Ventures. >> Click here for more funding data on Axial Biotherapeutics >> To export Axial Biotherapeutics funding data to PDF a... |
| 28.02.2019 | Axial Biotherapeutics nets $25M for clinical gut-brain axis studies into autism and Parkinson’s | Axial Biotherapeutics has raised $25 million to fund its programs aimed at the gut microbiome, for the treatment of Parkinson’s disease and autism spectrum disorder. Seventure Partners led the series B round, through its microbiome-focused ... |
| 27.02.2019 | Axial Biotherapeutics Raises $25M in Series B Financing | Axial Biotherapeutics, a Waltham, MA-based biotechnology company dedicated to building a unique class of gut-targeted programs for neurodegenerative and neuropsychiatric diseases, completed a $25m series B equity financing. The round was le... |
| 27.02.2019 | Axial Biotherapeutics Finds $25M For Parkinson's, Autism Treatments | Pasadena-based Axial Biotherapeutics, a biotechnology company which is focused on developing treatments for Parkinson's disease and Autism Spectrum Disorder, has raised $25M in its Series B funding round, the company announced this morning.... |
| 27.02.2019 | Axial Biotherapeutics Raises $25 Million in Series B Financing | WALTHAM, Mass. & PASADENA, Calif.--(BUSINESS WIRE)--Axial Biotherapeutics, a biotechnology company dedicated to building a unique class of gut-targeted programs for neurodegenerative and neuropsychiatric diseases, today announced the co... |
Show more